Endovascular Treatment Key Technique and Emergency Work Flow Improvement of Acute Ischemic Stroke — ANGEL-ACT  

Intracranial Artery Occlusion With Infarction (Disorder) Clinical Trial

Official title: Endovascular Treatment Key Technique and Emergency Work Flow Improvement of Acute Ischemic stroke-a Prospective Multicenter Registry Study

Status Completed

Clinical Trial Summary

Endovascular thrombectomy (EVT) is effective and safe for acute ischemic stroke (AIS) caused by large vessel occlusion (LVO) in major clinical trials. Whether the benefit of EVT in randomized trials could be generalized to clinical practice, especially in developing countries, remains unknown. The prospective Chinese ANGEL-ACT Registry (Endovascular Treatment Key Technique and Emergency Work Flow Improvement of Acute Ischemic Stroke) was established to evaluate the utilization, and subsequent outcomes of EVT treated AIS patients. This study is a multi-center, prospective registry study initiated by researchers, funded by National Key R&D Program of China. A total of 2,000 patients with acute ischemic stroke will undergo endovascular treatment. The hypothesis was that favorable outcomes from clinical trials could be achieved in clinical practice in China.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Emergencies
• Infarction
• Intracranial Artery Occlusion With Infarction (Disorder)

• NCT number: NCT03370939
• Study type: Observational [Patient Registry]
• Source: Beijing Tiantan Hospital
• Status: Completed
• Start date: November 11, 2017
• Completion date: July 7, 2019